Follow

"Antibody-drug conjugates (ADCs) have a long but somewhat convoluted history in drug discovery. The idea seems straightforward, though: combining the extraordinary selectivity and long half-lives of antibody proteins with the target-directed effects of a small-molecule drug. In practice, as is so often the case, it’s Not So Simple."

science.org/content/blog-post/

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.